Inventiva (IVA) Dividends Paid - Common (2019 - 2022)
Inventiva (IVA) posted quarterly Dividends Paid - Common of $78.0 million for Q4 2022, down 27.22% year-over-year from $107.1 million in Q4 2021, and down 2.22% quarter-over-quarter from $79.7 million in Q3 2022.
Inventiva (IVA) Dividends Paid - Common (2019 - 2022) Analysis & Trends
Inventiva's Dividends Paid - Common history runs 4 years deep, the most recent figure standing at $78.0 million for Q4 2022.
- In Q4 2022, Dividends Paid - Common fell 27.22% year-over-year to $78.0 million; the TTM figure through Dec 2022 stood at $247.7 million (down 12.28% YoY), while the FY2022 annual figure was $78.0 million, down 27.22% from the prior year.
- Dividends Paid - Common for Q4 2022 stood at $78.0 million, down from $79.7 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $130.0 million in Q1 2021, with the low at -$17.1 million in Q2 2021.
- The 4-year median for Dividends Paid - Common is $62.3 million (2020), against an average of $59.9 million.
- Peak annual rise in Dividends Paid - Common reached 151.2% in 2021, while the deepest fall reached 388.03% in 2021.
- Inventiva's Dividends Paid - Common stood at $41.0 million in 2019, then soared by 51.92% to $62.3 million in 2020, then jumped by 71.86% to $107.1 million in 2021, then retreated by 27.22% to $78.0 million in 2022.
- Business Quant data shows IVA's Dividends Paid - Common at $78.0 million in Q4 2022, $79.7 million in Q3 2022, and $107.1 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 77.95 Mn |
| Dec 31, 2022 | 77.95 Mn |
| Sep 22, 2022 | 79.73 Mn |
| Sep 22, 2022 | 79.73 Mn |
| Dec 31, 2021 | 107.11 Mn |
| Dec 31, 2021 | 107.11 Mn |
| Jun 30, 2021 | -17.07 Mn |
| Jun 30, 2021 | -17.07 Mn |
| Mar 31, 2021 | 130.04 Mn |
| Mar 31, 2021 | 130.04 Mn |
| Dec 31, 2020 | 62.32 Mn |
| Dec 31, 2020 | 62.32 Mn |
| Jun 30, 2020 | 5.93 Mn |
| Jun 30, 2020 | 5.93 Mn |
| Mar 31, 2020 | 51.77 Mn |
| Mar 31, 2020 | 51.77 Mn |
| Dec 31, 2019 | 41.03 Mn |
| Dec 31, 2019 | 41.03 Mn |